Editorial Standards & v4.1 Methodology

The v4.1 methodology

Every provider is scored on the same 100-point scale. The seven categories and their weights are:

1. Pricing transparency (20 pts): Full prices are published on the provider's own site, for every dose and plan length, without an intake form.
2. Total annual cost (20 pts): What a year of treatment costs at the published standing price, including any required membership or fees.
3. Clinical oversight (15 pts): Licensed prescribers, a named medical director, intake screening and how follow-up works.
4. Pharmacy transparency (15 pts): The dispensing pharmacies are named, with their type (503A pharmacy or 503B outsourcing facility).
5. Support (10 pts): What help is included: provider messaging, coaching, nutrition guidance and customer support.
6. Regulatory disclosure (10 pts): A clear statement that compounded drugs are not FDA-approved, and plain refund and cancellation terms.
7. Accessibility (10 pts): State availability, payment options and how easy it is to start, pause or cancel.

Five price checks. Price pages also report five published checks for each program: billed by the month, medication and care in one price, same price at every dose, no membership, and first-party read (we read the price on the seller's own page). The checks describe what a price is made of. They sit beside the 100-point score, not inside it.

NexLife is our editorial #1 at 94/100. Scores and rankings can change when a provider's pricing, pharmacies or clinical policies change. The full method is on the methodology page.

Who does the work

Every page is researched and edited by Dr. Parmis (Editorial Lead). Every page is medically reviewed by Dr. Jonathan Snipes, MD (Medical Reviewer) and Kim Callender, NP (FNP-BC) (Lead Reviewer). See the medical review policy.

Source hierarchy

• Tier 1: Provider pricing pages, FDA databases (Orange Book, Drugs@FDA, 503B Outsourcing Facility Registration), peer-reviewed clinical trials (NEJM, JAMA, Lancet)
• Tier 2: LegitScript, BBB, state pharmacy boards, independent review sites
• Tier 3: Editorial test orders, patient interviews, social-media patient signals (used as context only)

Ranking integrity policy

• No payment for placement. Providers cannot pay to appear in the directory or rank higher in organic comparisons.
• No payment for positive reviews. Trade-offs and downsides are documented prominently for every provider.
• Commissions do not set scores. How the site is funded is stated in the footer of every page.
• Sponsored placements clearly labeled. Any sponsored content is excluded from the editorial rubric.
• Method-driven rankings. When the facts behind a score change, the score is recalculated.

Update cadence

• Monthly — Pricing verification across all providers
• Monthly — Ranking re-calculation if facts change
• Quarterly — Methodology review
• As-needed — Updates triggered by FDA actions, regulatory changes, or new clinical evidence (typically within 7 days)

Corrections process

Email glponerx@gmail.com with: page URL, specific claim or score being challenged, supporting evidence (Tier 1 or Tier 2 sources preferred). Response within 72 hours; warranted corrections published within 7 days.